Federal Supply Schedule V797D60712

This Federal Supply Schedule contract, awarded to R-Pharm US LLC (UEI: DCS8XNM7NMW7) on September 1, 2016, establishes a multiple-award indefinite delivery vehicle for the supply of pharmaceuticals, drugs, and hematology-related products under General Services Administration Schedule 61-IB. The contract, funded by the Department of Veterans Affairs through Veterans Integrated Service Network 12, carries a ceiling value of $444,187.20 and runs through August 31, 2026. As a civilian agency contract with no set-aside restrictions, this schedule allows the Veterans Integrated Service Network to procure pharmaceutical products on an as-needed basis throughout the contract period, ensuring consistent access to essential medications and hematology supplies for eligible beneficiaries.

The contract encompasses 65 items in the pharmaceutical and hematology category and includes a 2026 Public Law pricing update affecting two National Drug Codes. Federal Supply Schedules of this type provide the government with streamlined procurement mechanisms that leverage established pricing and simplified ordering procedures, reducing administrative burden while ensuring compliance with federal pricing requirements. The indefinite delivery structure allows Veterans Integrated Service Network 12 to place individual task orders or calls against the contract as inventory needs arise, with pricing governed by the schedule's discount structure and periodic updates to reflect current market conditions and regulatory pricing mandates.